Discontinued — last reported Q2 '23

Business Segments · Revenue

Segment operating income — Revenue

STERIS Segment operating income — Revenue increased by 5.6% to $1.28B in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $1.16B to $1.28B. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ2 2016
Last reportedQ2 2023
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or higher demand for the segment's products and services, whereas a decrease may signal market saturation or loss of competitive positioning.

Detailed definition

This metric measures the total gross inflow of economic benefits generated by a specific business segment from its prima...

Peer comparison

Comparable to segment-level net sales or revenue reported by peers in the medical device and healthcare services sectors.

Metric ID: ste_segment_segment_operating_income_revenues

Historical Data

7 periods
 Q2 '21Q3 '21Q4 '21Q2 '22Q3 '22Q4 '22Q2 '23
Value$968.42M$1.20B$1.21B$1.16B$1.20B$1.22B$1.28B
QoQ Change+23.6%+1.0%-4.3%+3.8%+1.3%+5.6%
YoY Change+19.4%+0.3%+0.6%+11.1%
Range$968.42M$1.28B
CAGR+20.7%
Avg YoY Growth+7.8%
Median YoY Growth+5.8%
Current Streak3 quarters growth

Frequently Asked Questions

What is STERIS's segment operating income — revenue?
STERIS (STE) reported segment operating income — revenue of $1.28B in Q2 2023.
How has STERIS's segment operating income — revenue changed year-over-year?
STERIS's segment operating income — revenue increased by 11.1% year-over-year, from $1.16B to $1.28B.
What does segment operating income — revenue mean?
The total sales revenue generated by a specific business segment before any expenses are deducted.